2.Can hormone replacement therapy be used following treatment for gynecologic malignancies?.
Yong-liang GAO ; Jian-qing ZHU
Chinese Journal of Oncology 2012;34(9):719-720
Adenocarcinoma
;
therapy
;
Breast Neoplasms
;
therapy
;
Carcinoma, Endometrioid
;
therapy
;
Carcinoma, Squamous Cell
;
therapy
;
Cystadenocarcinoma, Serous
;
therapy
;
Endometrial Neoplasms
;
therapy
;
Female
;
Genital Neoplasms, Female
;
therapy
;
Hormone Replacement Therapy
;
Humans
;
Ovarian Neoplasms
;
therapy
;
Treatment Outcome
;
Uterine Cervical Neoplasms
;
therapy
4.Experience on epidermal growth factor receptor gene mutation analysis in non-small cell lung cancer.
Jing ZHANG ; Jie GAO ; Zhi-yong LIANG ; Tong-hua LIU
Chinese Journal of Pathology 2011;40(10):712-714
Carcinoma, Non-Small-Cell Lung
;
genetics
;
metabolism
;
pathology
;
DNA Mutational Analysis
;
DNA, Neoplasm
;
genetics
;
isolation & purification
;
Genes, erbB-1
;
Humans
;
Lung Neoplasms
;
genetics
;
metabolism
;
pathology
;
Mutation
;
Paraffin Embedding
;
methods
;
Polymerase Chain Reaction
;
methods
;
Real-Time Polymerase Chain Reaction
;
methods
;
Receptor, Epidermal Growth Factor
;
genetics
5.Study of the Expression and Significance of P53 and nm23 in Colorectal Adenocarcinom.
Feng SONG ; Feng GAO ; Liang DONG ; Xin ZHANG ; Yong ZHAO
Journal of Medical Research 2006;0(02):-
Objective To study the expression and significance of P53 and nm23 in colorectal adenocarcinoma.Methods The expression of P53 and nm23 was examined by immunohistochemical technique in 83 cases of colorectal adenocarcinoma.Results In colorectal adenocarcinoma,the positive intensities of P53 and nm23 was associated with tumour depth,histological grade,lymph node metastasis diseases and distant metastasis disease(P0.05).Conclusion P53 and nm23 may play an important role in the development and metastasis of colorectal adenocarcinoma.It is an useful marker for predictinng the prognosis of colorectal adenocarcinoma.
6.Clinic study of dose-dense cisplatin and 5-fluorouracil in patients with distant metastatic nasopharyngeal carcinoma
Yong LIANG ; Jian FENG ; Boyu CHEN ; Weichao LIANG ; Kequan CHEN ; Weiwei GAO ; Yaocan XU
Journal of International Oncology 2015;(7):496-500
Objective To investigate the efficacy and tolerability of dose-dense chemotherapy with cisplatin plus 5-fluorouracil( PF regimen)in distant metastatic nasopharyngeal carcinoma( NPC)patients. Methods From April 1,2008 to April 30,2014,168 patients were assigned to traditional group(n = 83) and dose-dense group(n = 85)using digital random table in 1 : 1 ratio. All patients received PF regimen,and once every 28 days in traditional group and once every 14 days in dose-dense group. The primary endpoint was progression-free survival(PFS)and the secondary endpoint was overall survival(OS),toxicity and response rate. Results The median PFS,median OS,1,2,3-year survival rate,complete response rate and objective response rate were significantly improved in dose-dense group which were 13. 3 months,20. 2 months,80. 2% , 36. 0% ,16. 1% ,16. 5% ,84. 7% ,and those in control group were 10. 0 months,16. 1 months,59. 6% , 10. 1% ,0,3. 6% ,54. 2% respectively(χ2 = 24. 47,P = 0. 000;χ2 = 16. 65,P = 0. 000;χ2 = 8. 41,P =0. 004;χ2 = 16. 96,P = 0. 000;χ2 = 14. 91,P = 0. 000;χ2 = 7. 63,P = 0. 006;χ2 = 18. 47,P = 0. 000). The rates of grade 3-4 adverse events in dose-dense and traditional group were 38. 8% and 6. 0%(χ2 = 25. 81, P = 0. 000). Conclusion Dose-dense chemotherapy of PF is more efficient and acceptable toxic than the tra-ditional one. It can be a new treatment option for patients with distant metastases of NPC.
7.Behavior Therapy for relieving the symptoms of outpatients with schizophrenia
Yu-tao XIANG ; Wen-yong LI ; Yong-zhen WENG ; Yezhi HOU ; Liang GAO ; Guolan CHEN
Chinese Journal of Rehabilitation Theory and Practice 2002;8(11):682-684
ObjectiveTo study the effects of the Behavior Therapy on outpatient with schizophrenics in relieving symptoms, insight, and attitude to treatment. Methods96 outpatients with schizophrenia were randomly assigned to the Behavior Therapy group and the control group. The Behavior Therapy courses were given to the Behavior Therapy group for six months. All the subjects were evaluated with Positive and Negative Syndrome Scale(PANSS) and Insight and Therapeutic Attitude questionaire(ITAQ). Results94 cases completed the trial. The scores of PANSS, the Negative Subscale, the General Psychopathology Subscale of the Behavior Therapy group decreased significantly after treatment(P<0.01). The score of ITAQ of the Behavior Therapy group increased significantly after treatment(P<0.01).The reductions of PANSS, the Positive Subscale, the Negative Subscale, the General Psychopathology Subscale and ITAQ between two groups were significant different(P<0.05-P<0.01). Conclusions The Behavior Therapy may play an important role in augmenting optimal pharmacotherapy for outpatients with schizophrenia and it is effective in improving symptoms, insight and therapeutic attitude.
8.Combined effect of cosolvent and cyclodextrin on solubilization of insoluble drugs.
Acta Pharmaceutica Sinica 2006;41(10):950-955
AIMTo investigate the combined effect of cosolvent and cyclodextrin (CD) on solubilization of insoluble drugs.
METHODSPhase-solubility method was applied to determine solubilization of two diterpenoids in cosolvent / cyclodextrin combinations. The combined effect was evaluated and explained with an established mathematical model, and the model parameters were calculated by means of nonlinear regression analysis.
RESULTSThe strong agreement between the predicted and the observed solubility data supports the validity of the proposed model, with the determination coefficients of two regression models were 0.993 and 0.992, separately.
CONCLUSIONThe validated mathematical model can be used to explain and predict the combined solubilization of the two insoluble drugs in different cosolvent systems.
2-Hydroxypropyl-beta-cyclodextrin ; Algorithms ; Diterpenes ; chemistry ; Models, Chemical ; Solubility ; Solvents ; chemistry ; Water ; chemistry ; beta-Cyclodextrins ; chemistry
9.Application of high-throughput technologies in pharmaceutics.
Acta Pharmaceutica Sinica 2006;41(6):487-492
10.Hierarchical chain management model in blood glucose control and its influence factors in patients with diabetes mellitus
Qingge GAO ; Yi WANG ; Chao SHI ; Rong CHEN ; Changxiu LIANG ; Yanrong LU ; Yong ZHOU
Chinese Journal of Postgraduates of Medicine 2012;35(19):7-10
Objective To explore the hierarchical chain management model in blood glucose control and its influence factors in patients with diabetes mellitus.Methods Health management database of diabetic patients was established in 2007 and managed by hierarchical chain management.The number of the patients reached to 1010 till 2011.The blood glucose control of diabetic patients was analyzed and its influence factors were analyzed by multivariate unconditional Logistic regression method.Results The concentration of glycosylated hemoglobin( HbA1c ) of 1010 patients with type 2 diabetes was (8.21 ±:2.70)%.Four hundred and eighty-seven cases (48.22%) reached the blood glucose standard,303 cases (30.00%)reached the blood pressure standard,245 cases (24.26%) reached the blood lipids standard,and 76 cases (7.52%) reached all three standards.Multivariate analysis showed that occupation (OR =2.521,95% CI:1.871 - 3.397),education level (OR =1.890,95% CI:1.642 - 2.174),disease course (OR =1.035,95%CI:1.016 -1.055),systolic pressure (OR =1.016,95% CI:1.007 -1.025) and triglyceride (OR =1.204,95%CI:1.063 - 1.365) were the risk factors of blood glucose control (P <0.01).Conclusions Hierarchical chain management model is helpful for the blood glucose control in patients with type 2 diabetes.The comprehensive control and treatment of type 2 diabetes should be taken combined with related risk factors,such as blood pressure,blood lipids and diabetes disease course.